Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1031 | 917 | 1031 | 1034 | 1232 | 1607 |
Fund Return | 3.13% | -8.29% | 3.13% | 1.11% | 4.27% | 4.86% |
Place in category | 506 | 511 | 506 | 245 | 340 | 226 |
% in Category | 74 | 71 | 74 | 44 | 60 | 60 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VALIC Company I Stock Index | 6.97B | 24.66 | 8.60 | 12.74 | ||
VALIC Company I Science & Technolog | 3.07B | 32.60 | 8.02 | 17.41 | ||
VALIC Company I Mid Cap Index | 3.02B | 13.51 | 4.47 | 9.32 | ||
VALIC Company I Growth | 1.87B | 32.74 | 7.65 | 14.46 | ||
VALIC Company I Blue Chip Growth | 1.08B | 34.48 | 6.02 | 14.17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 201.2B | 5.09 | 0.61 | 5.00 | ||
Vanguard Total Intl Stock Index Adm | 72.9B | 5.14 | 0.67 | 5.06 | ||
Fidelity International Index Inst | 51.28B | 3.71 | 1.71 | 5.38 | ||
Fidelity Series Global ex US Index | 50.22B | 5.35 | 0.85 | 4.86 | ||
Strategic Advisers International I | 44.17B | 5.63 | 0.87 | 6.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.03 | 622.4 | 0.00% | |
ASML Holding | NL0010273215 | 1.62 | 651.60 | -7.01% | |
SAP | DE0007164600 | 1.47 | 261.400 | -0.82% | |
Nestle | CH0038863350 | 1.34 | 77.56 | +3.86% | |
Novartis | CH0012005267 | 1.23 | 92.22 | +2.17% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Sell | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review